These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9694729)

  • 1. The chimeric E2A-HLF transcription factor abrogates p53-induced apoptosis in myeloid leukemia cells.
    Altura RA; Inukai T; Ashmun RA; Zambetti GP; Roussel MF; Look AT
    Blood; 1998 Aug; 92(4):1397-405. PubMed ID: 9694729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The AD1 and AD2 transactivation domains of E2A are essential for the antiapoptotic activity of the chimeric oncoprotein E2A-HLF.
    Inukai T; Inaba T; Ikushima S; Look AT
    Mol Cell Biol; 1998 Oct; 18(10):6035-43. PubMed ID: 9742120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pivotal role for the NFIL3/E4BP4 transcription factor in interleukin 3-mediated survival of pro-B lymphocytes.
    Ikushima S; Inukai T; Inaba T; Nimer SD; Cleveland JL; Look AT
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2609-14. PubMed ID: 9122243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proto-oncogene HLF and the related basic leucine zipper protein TEF display highly similar DNA-binding and transcriptional regulatory properties.
    Hunger SP; Li S; Fall MZ; Naumovski L; Cleary ML
    Blood; 1996 Jun; 87(11):4607-17. PubMed ID: 8639829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E2A-HLF oncoprotein activates Groucho-related genes and suppresses Runx1.
    Dang J; Inukai T; Kurosawa H; Goi K; Inaba T; Lenny NT; Downing JR; Stifani S; Look AT
    Mol Cell Biol; 2001 Sep; 21(17):5935-45. PubMed ID: 11486032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of apoptosis by the leukaemia-associated E2A-HLF chimaeric transcription factor.
    Inaba T; Inukai T; Yoshihara T; Seyschab H; Ashmun RA; Canman CE; Laken SJ; Kastan MB; Look AT
    Nature; 1996 Aug; 382(6591):541-4. PubMed ID: 8700228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-binding specificity and trans-activating potential of the leukemia-associated E2A-hepatic leukemia factor fusion protein.
    Inaba T; Shapiro LH; Funabiki T; Sinclair AE; Jones BG; Ashmun RA; Look AT
    Mol Cell Biol; 1994 May; 14(5):3403-13. PubMed ID: 8164688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E4BP4 expression is regulated by the t(17;19)-associated oncoprotein E2A-HLF in pro-B cells.
    Yeung J; O'Sullivan E; Hubank M; Brady HJ
    Br J Haematol; 2004 Jun; 125(5):560-7. PubMed ID: 15147370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformation of bone marrow B-cell progenitors by E2a-Hlf requires coexpression of Bcl-2.
    Smith KS; Rhee JW; Cleary ML
    Mol Cell Biol; 2002 Nov; 22(21):7678-87. PubMed ID: 12370314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA-binding and transcriptional regulatory properties of hepatic leukemia factor (HLF) and the t(17;19) acute lymphoblastic leukemia chimera E2A-HLF.
    Hunger SP; Brown R; Cleary ML
    Mol Cell Biol; 1994 Sep; 14(9):5986-96. PubMed ID: 8065331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TEF, an antiapoptotic bZIP transcription factor related to the oncogenic E2A-HLF chimera, inhibits cell growth by down-regulating expression of the common beta chain of cytokine receptors.
    Inukai T; Inaba T; Dang J; Kuribara R; Ozawa K; Miyajima A; Wu W; Look AT; Arinobu Y; Iwasaki H; Akashi K; Kagami K; Goi K; Sugita K; Nakazawa S
    Blood; 2005 Jun; 105(11):4437-44. PubMed ID: 15665112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma inhibits apoptosis induced by wild-type p53, cytotoxic anti-cancer agents and viability factor deprivation in myeloid cells.
    Lotem J; Sachs L
    Leukemia; 1995 Apr; 9(4):685-92. PubMed ID: 7723404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SLUG, a ces-1-related zinc finger transcription factor gene with antiapoptotic activity, is a downstream target of the E2A-HLF oncoprotein.
    Inukai T; Inoue A; Kurosawa H; Goi K; Shinjyo T; Ozawa K; Mao M; Inaba T; Look AT
    Mol Cell; 1999 Sep; 4(3):343-52. PubMed ID: 10518215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell transformation mediated by homodimeric E2A-HLF transcription factors.
    Inukai T; Inaba T; Yoshihara T; Look AT
    Mol Cell Biol; 1997 Mar; 17(3):1417-24. PubMed ID: 9032268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two candidate downstream target genes for E2A-HLF.
    Kurosawa H; Goi K; Inukai T; Inaba T; Chang KS; Shinjyo T; Rakestraw KM; Naeve CW; Look AT
    Blood; 1999 Jan; 93(1):321-32. PubMed ID: 9864177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors.
    de Boer J; Yeung J; Ellu J; Ramanujachar R; Bornhauser B; Solarska O; Hubank M; Williams O; Brady HJ
    Leukemia; 2011 Feb; 25(2):321-30. PubMed ID: 21072044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19).
    Hirose K; Inukai T; Kikuchi J; Furukawa Y; Ikawa T; Kawamoto H; Oram SH; Göttgens B; Kiyokawa N; Miyagawa Y; Okita H; Akahane K; Zhang X; Kuroda I; Honna H; Kagami K; Goi K; Kurosawa H; Look AT; Matsui H; Inaba T; Sugita K
    Blood; 2010 Aug; 116(6):962-70. PubMed ID: 20519628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2A-HLF-mediated cell transformation requires both the trans-activation domains of E2A and the leucine zipper dimerization domain of HLF.
    Yoshihara T; Inaba T; Shapiro LH; Kato JY; Look AT
    Mol Cell Biol; 1995 Jun; 15(6):3247-55. PubMed ID: 7760820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells.
    Hastak K; Gupta S; Ahmad N; Agarwal MK; Agarwal ML; Mukhtar H
    Oncogene; 2003 Jul; 22(31):4851-9. PubMed ID: 12894226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2A-HLF usurps control of evolutionarily conserved survival pathways.
    Seidel MG; Look AT
    Oncogene; 2001 Sep; 20(40):5718-25. PubMed ID: 11607821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.